Paul Linton Alderman, Chief Strategy/Transformation Officer of FTI Consulting, Inc., filed a Form 4 on November 19, 2026, disclosing a stock option exercise and same-day sale of 2,500 shares of common stock on November 17, 2026.
Key Highlights
- Option exercise: Alderman acquired 2,500 shares of common stock on November 17, 2026, via an option exercise (transaction code M) at a price of $40.36 per share.
- Same-day sale: Alderman disposed of 2,500 shares on November 17, 2026, at a price of $207 per share (transaction code S).
- Remaining holdings: Following the transactions, Alderman directly beneficially owned 92,824 shares of common stock.
- Derivative securities: Following the exercise, Alderman holds 3,977 stock options (right to buy) with an exercise price of $40.36, expiring March 6, 2027.
- Options fully vested: According to the filing, the exercised options "vested and became exercisable in full on March 6, 2020."
- Filed by attorney-in-fact: The form was signed by Michael Rosenthall as attorney-in-fact for Paul Linton on November 19, 2026.
FTI Consulting Officer Reports Option Exercise and Share Disposition in November 2026
According to the Form 4 filed with the SEC on November 19, 2026, Paul Linton Alderman, identified in the filing as Chief Strategy/Transf. Officer of FTI Consulting, Inc. (NYSE:FCN), reported two transactions in the company's common stock, both dated November 17, 2026. The filing covers non-derivative and derivative securities activity in Table I and Table II, respectively.
In the non-derivative table, the filing discloses that Alderman acquired 2,500 shares through an option exercise (code M) at $40.36 per share, bringing his holdings to 95,324 shares at that point. He then disposed of 2,500 shares via a sale (code S) at $207 per share, reducing his directly held beneficial ownership to 92,824 shares. All ownership is reported as direct.
In the derivative securities table, the filing shows that 2,500 stock options with an exercise price of $40.36 were exercised on November 17, 2026. The filing notes in its explanation of responses that "all options pursuant to these awards vested and became exercisable in full on March 6, 2020." The expiration date listed for the underlying option series is March 6, 2027. After the exercise, Alderman retains 3,977 stock options in this series, held directly.
What Was Disclosed
The filing reports that Alderman exercised 2,500 vested stock options at $40.36 and sold 2,500 shares at $207 on November 17, 2026, leaving him with 92,824 shares of common stock and 3,977 remaining stock options directly held.



Please wait processing your request...